A new prospective trial finds AI assistance significantly increases detection of suspicious lung nodules in low-dose chest CT screenings.
Key Details
- 1Published in American Journal of Roentgenology; study compares radiologist performance with and without AI support.
- 2First prospective real-world evidence addressing limitations of prior retrospective research on AI in lung cancer screening.
- 3Study involved consecutive asymptomatic patients undergoing low-dose chest CT from May to September 2025.
- 4Patients were randomized to AI-assisted interpretation or radiologist-only reading arms.
- 5Primary outcomes measured: interpretation times and nodule detection rates, with secondary analysis on follow-up recommendations.
Why It Matters
Prospective, real-world data are essential for validating AI performance beyond retrospective analyses. The results support integrating AI into routine lung cancer screening, potentially improving early lung cancer detection and workflow efficiency.
Source
Radiology Business
Related News
•AuntMinnie
AI Triage Tool Speeds Up ICH Head CT Turnaround in ED
AI-based triage for intracranial hemorrhage on head CT reduced emergency department report turnaround by 13 minutes.
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.
•Radiology Business
UC Irvine Implements AI to Find Lung Cancer Screening Candidates
UC Irvine's radiology department developed an NLP tool to identify patients eligible for lung cancer screening from EHR notes.